SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who wrote (561)6/10/1999 9:36:00 AM
From: Mike McFarland  Read Replies (1) of 4474
 
asgt.org never updated the program to account
for these new names listed in the Ariad PR--
still says Michael Gilman, ARIAD Pharmaceuticals
Imparting small molecule control to cell and gene therapies
(and he is also listed in the meet the investigator/
breakfast section).

Also noticed
Stem Cells
Chair: Irving Weissman, Stanford University
--ah, but that is another stock.

I see Poodle and Peter are bearish on the BB's
Message 10043861
Maybe aria and ctii can join my other two delisted stocks
to give these guys a good chuckle.

Okay, now I really have to wind this up--daysleeper can
dream of sugar plums and rising stocks, gee, I did not
even know Ariad had a "new regulated protein secretion
system for the treatment of diabetes."

Hope the wife doesn't see that PR, if Ariad pops up over
the next couple weeks I'll be getting a lot of grief for
swapping it out for Magainin. Ouch.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News